These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 88594)

  • 1. Genetically determined variability in drug metabolism: dual slow acetylation and drug oxidation traits.
    Mahgoub A; Idle JR; Smith RL
    Lancet; 1979 Jul; 2(8134):154. PubMed ID: 88594
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in drug metabolism.
    Alván G
    J Intern Med; 1992 Jun; 231(6):571-3. PubMed ID: 1619380
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW
    N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicological implications of polymorphic drug metabolism.
    Ritchie JC; Sloan TP; Idle JR; Smith RL
    Ciba Found Symp; 1980; 76():219-44. PubMed ID: 6906263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphic drug oxidation--much ado about nothing?
    Lancet; 1984 Jun; 1(8390):1337. PubMed ID: 6145034
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetically determined adverse drug reactions involving metabolism.
    Lennard MS
    Drug Saf; 1993 Jul; 9(1):60-77. PubMed ID: 8347292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic polymorphism of drug oxidation].
    Heller FR; Leclercq V; Harvengt C
    Acta Gastroenterol Belg; 1988; 51(1):91-101. PubMed ID: 3055790
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the patient a fast or a slow acetylator?
    Drug Ther Bull; 1974 Mar; 12(6):21-2. PubMed ID: 4457304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Individual variations in the oxidative metabolism of drugs. Significance of monogenic polymorphism].
    Brøsen K
    Ugeskr Laeger; 1984 Mar; 146(13):955-9. PubMed ID: 6719598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical consequences of acetylation polymorphism].
    Jendryczko A; Gmiński J
    Pol Tyg Lek; 1984 Sep; 39(37):1249-52. PubMed ID: 6150471
    [No Abstract]   [Full Text] [Related]  

  • 14. Human genetic variations in oxidative drug metabolism.
    Xenobiotica; 1986 May; 16(5):359-509. PubMed ID: 3739362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J; Bergmann JF; Caulin C; Segrestaa JM
    Therapie; 1990; 45(2):91-7. PubMed ID: 2191470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetically determined abnormal reactions to drugs].
    Prandota J; Iwańczak F; Panków-Prandota L
    Pediatr Pol; 1980 Apr; 55(4):525-30. PubMed ID: 6997825
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease and acetylation polymorphism.
    Lunde PK; Frislid K; Hansteen V
    Clin Pharmacokinet; 1977; 2(3):182-97. PubMed ID: 328206
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability in drug metabolism: importance of genetic constitution.
    Schellens JH; Breimer DD
    Pharm Weekbl Sci; 1987 Apr; 9(2):85-90. PubMed ID: 3295765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
    Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
    Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.